8-K: DHC Navigates Q3 with Strategic Debt Moves & Occupancy Gains

Diversified Healthcare Trust reports mixed Q3 2025 results, showing operational improvements in occupancy and leasing, alongside a significant net loss and strategic debt refinancing efforts.

Summary

• Reported a net loss of $164.0 million, or $0.68 per share, for the quarter ended September 30, 2025.
• Normalized FFO increased significantly to $9.7 million, or $0.04 per share, up 141.5% year-over-year.
• Adjusted EBITDAre was $62.8 million, a 5.9% decrease year-over-year.
• SHOP segment occupancy increased by 210 basis points year-over-year to 81.5%, with average monthly rates growing over 5%.
• Medical Office and Life Science Portfolio occupancy rose by 580 basis points year-over-year to 86.6%.
• Leased 85,992 square feet in the Medical Office and Life Science Portfolio at weighted average rents 9.1% higher than prior rates.
• Consolidated SHOP Net Operating Income (NOI) increased 8.0% year-over-year to $29.6 million, despite temporary impacts from elevated labor costs due to operator transitions.
• Successfully issued $375.0 million of senior secured notes due 2030 and used a portion of proceeds to partially redeem $307.0 million of senior secured notes due 2026.
• Received a $28.0 million distribution from the Seaport Innovation LLC joint venture following a $1.0 billion mortgage loan refinancing.
• Sold 6 unencumbered properties for $16.5 million in Q3 2025, and an additional 12 properties for $42.1 million since October 1, 2025, with proceeds used for debt redemption.
• As of November 3, 2025, 85 of 116 AlerisLife-managed communities have transitioned to new operators, with full completion expected by year-end.
• Under agreements or letters of intent to sell 38 properties for an aggregate of $237.2 million.

Sentiment

Score: 5

Explanation: While operational metrics like occupancy and rent growth in key segments are strong, and debt management is proactive, the substantial net loss, high impairment charges, and decreased Adjusted EBITDAre indicate significant financial challenges. The positive operational trends are somewhat offset by these financial headwinds and the temporary impact of transitions.

Positives

• Normalized FFO increased by 141.5% year-over-year to $9.7 million, or $0.04 per share.
• SHOP segment occupancy improved by 210 basis points year-over-year to 81.5%.
• SHOP average monthly rates grew by over 5% year-over-year, leading to a 6.9% increase in SHOP revenues.
• Consolidated SHOP NOI increased by 8.0% year-over-year to $29.6 million.
• Medical Office and Life Science Portfolio occupancy significantly increased by 580 basis points year-over-year to 86.6%.
• Medical Office and Life Science Portfolio leasing activity showed strong momentum, with weighted average rents 9.1% higher than prior rates for 85,992 square feet leased.
• Strengthened the balance sheet by issuing $375.0 million in new senior secured notes due 2030 and using proceeds to partially redeem $307.0 million of senior secured notes due 2026.
• Received a $28.0 million distribution from the Seaport Innovation LLC joint venture.
• Strategic property sales are contributing to debt reduction, with $10.2 million from a recent sale used to partially redeem 2026 notes.
• The transition of AlerisLife-managed communities is on track, with 73% completed as of November 3, 2025, and full completion expected by year-end.
• CAD increased significantly to $17.2 million in Q3 2025 from $(12.8) million in Q3 2024.
• Adjusted EBITDAre / interest expense improved to 1.3x in Q3 2025 from 1.1x in Q3 2024.

Negatives

• Reported a net loss of $164.0 million, or $0.68 per share, a 66.2% increase in net loss year-over-year.
• Adjusted EBITDAre decreased by 5.9% year-over-year to $62.8 million.
• Consolidated Same Property Cash Basis NOI only increased by 0.7% year-over-year.
• SHOP Same Property Cash Basis NOI decreased by 1.2% year-over-year.
• Medical Office and Life Science Portfolio consolidated rental income decreased by 8.8% year-over-year.
• Medical Office and Life Science Portfolio consolidated NOI decreased by 4.1% year-over-year.
• Impairment of assets significantly increased to $93.2 million in Q3 2025 from $23.0 million in Q3 2024.
• Incurred a loss on modification or early extinguishment of debt of $11.2 million in Q3 2025.
• Elevated labor costs temporarily impacted SHOP NOI due to the AlerisLife community transitions.
• Total gross assets and total equity have been on a decreasing trend over the past year.

Risks

• Unfavorable market and commercial real estate industry conditions, including reduced demand for healthcare-related space and senior living communities, interest rate uncertainties, wage and commodity price inflation, supply chain disruptions, and volatility in public debt and equity markets.
• The ability of DHC's senior living operators to successfully and profitably operate the communities they manage.
• The continuing impact of changing market practices, such as delayed recovery of the senior housing industry, reduced demand for leased medical office, life science, and other space, and increased operating costs.
• The financial strength of DHC's managers and other operators and tenants.
• Temporary disruption, including reductions in cash flows, due to the transition of 116 senior living communities from AlerisLife to new operators.
• Uncertainty regarding whether tenants will renew or extend leases or if replacement tenants can be secured on favorable terms.
• The likelihood that tenants and residents will pay rent or be negatively impacted by continuing unfavorable market and commercial real estate industry conditions.
• Risks and uncertainties regarding the costs and timing of development, redevelopment, and repositioning activities, including inflation, cost overruns, tariffs, supply chain challenges, labor shortages, and construction delays.
• DHC's ability to comply with financial covenants under its debt agreements and make required debt payments.
• DHC's ability to maintain sufficient liquidity and manage leverage, as well as its credit ratings.
• The ability to sell properties at targeted prices or returns, and the timing of such sales.
• Potential conflicts of interest with related parties, including DHC's Managing Trustees, RMR, ABP Trust, AlerisLife, and others affiliated with them.
• Government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements.
• Compliance with, and changes to, federal, state and local laws and regulations, accounting rules, tax laws and similar matters.
• Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.
• Limitations imposed by and DHC's ability to satisfy complex rules to maintain DHC's qualification for taxation as a REIT for U.S. federal income tax purposes.
• Acts of terrorism, outbreaks of pandemics or other public health safety events or conditions, war or other hostilities, global climate change or other manmade or natural disasters beyond DHC's control.

Future Outlook

Management anticipates that labor expenses in the Senior Housing Operating Portfolio (SHOP) segment will normalize as the transition of AlerisLife communities concludes by year-end. The company intends to repay its 2026 debt maturity as early as year-end 2025, aiming to enter 2026 with no debt maturities until 2028. These strategic actions are expected to position Diversified Healthcare Trust to deliver attractive returns to shareholders in the years ahead.

Management Comments

• "During the third quarter, DHC continued to deliver operational improvements and further strengthened its balance sheet."
• "Our Medical Office and Life Science Portfolio continues to show robust leasing momentum, with weighted average rents 9% above prior rates and occupancy rising to 86.6%."
• "Our Senior Housing Operating Portfolio (SHOP) segment experienced a year-over-year occupancy increase of 210 basis points to 81.5%, alongside an average monthly rate growth of over 5%, reflecting strong demand and effective rate management."
• "The transition of 116 AlerisLife-managed communities to new operators remains on track, with approximately 73% of the portfolio transitioned to date and full completion expected by year-end."
• "While near-term labor costs have been elevated due to these transitions, impacting SHOP NOI, we anticipate labor expenses will normalize as the transition process concludes."
• "Supported by recent financing activities and asset sales, we intend to repay our 2026 debt maturity as early as year-end and enter 2026 with no debt maturities until 2028."
• "These significant actions taken this year position DHC to deliver attractive returns to shareholders in the years ahead."

Industry Context

The results reflect a mixed but generally improving environment for healthcare REITs. The strong occupancy and rent growth in the Medical Office and Life Science Portfolio align with continued demand for specialized healthcare and biotech real estate. The Senior Housing Operating Portfolio (SHOP) segment's occupancy and rate growth suggest a recovery in the senior living sector, although temporary elevated labor costs due to operator transitions highlight ongoing operational challenges common across the industry. Strategic debt management and asset dispositions are critical for REITs to optimize capital structures in a volatile interest rate environment.

Comparison to Industry Standards

• The 9.1% increase in weighted average rents for new and renewed leases in the Medical Office and Life Science Portfolio is a strong indicator, potentially outperforming some general office REITs facing headwinds. For example, while general office REITs might see flat to negative rent growth, specialized life science and medical office properties often command premiums due to specific infrastructure requirements and tenant stickiness.
• The 210 basis point year-over-year occupancy increase in the SHOP segment to 81.5% suggests a solid recovery, potentially outpacing the broader senior housing industry's average occupancy growth, which has been gradually recovering from pandemic lows but still faces labor and supply challenges. Specific comparable companies like Ventas (VTR) or Welltower (WELL) often report similar trends, but DHC's specific portfolio mix and transition efforts make direct comparison complex without their latest reports.
• The company's net debt to total gross assets of 38.1% is within a reasonable range for REITs, though some peers might target lower leverage depending on their asset class and growth strategy. For instance, a highly diversified REIT might aim for 30-35%, while a growth-oriented one might tolerate higher.
• The Adjusted EBITDAre / interest expense ratio of 1.3x indicates that the company's earnings are covering its interest obligations, but it's on the lower side compared to highly rated REITs which often have coverage ratios of 2.5x or higher, suggesting some financial strain or higher cost of debt.

Related Party Transactions

• DHC is managed by The RMR Group (Nasdaq: RMR), an alternative asset management company.
• DHC recognized incentive management fees of $5,676 thousand during the three months ended September 30, 2025, payable to RMR.
• The filing notes potential conflicts of interest with DHC's related parties, including DHC's Managing Trustees, RMR, ABP Trust, AlerisLife, and others affiliated with them, as a risk factor.

Stakeholder Impact

• Shareholders are impacted by the net loss of $0.68 per share, but also by the increased Normalized FFO of $0.04 per share and consistent $0.01 quarterly dividend. Strategic debt reduction and operational improvements aim to deliver attractive returns in the future.
• Employees at the 116 AlerisLife-managed communities undergoing transition to new operators could experience changes, though the filing emphasizes a "smooth transition."
• Customers (Residents/Tenants) in the SHOP segment are experiencing average monthly rate growth of over 5%, indicating potential cost increases. Medical office and life science tenants are seeing rent increases of 9.1% on new/renewed leases. Occupancy improvements suggest continued demand for DHC's properties.
• Creditors should view the company's proactive debt refinancing and partial redemption of 2026 notes, along with maintaining compliance with bond covenants, positively, as it reduces near-term refinancing risk.

Next Steps

• Conference call to discuss Q3 2025 financial results on November 4, 2025.
• Completion of management transitions for the remaining 31 AlerisLife communities by year-end 2025.
• Intend to repay 2026 debt maturity as early as year-end 2025.
• Expected sales of 38 properties under agreement or letter of intent for an aggregate of $237.2 million.
• Redevelopment projects for Pueblo Norte Senior Living (Q1 2026 / Q3 2027 completion) and Residences of Chevy Chase (Q2 2026 completion).

Key Dates

Recommendation

Diversified Healthcare Trust presents a mixed financial picture. While the significant net loss and asset impairments are concerning, the company demonstrates strong operational improvements in both its Senior Housing Operating Portfolio (SHOP) and Medical Office and Life Science segments, with rising occupancy and rent growth. Proactive debt management, including refinancing and early redemption of near-term maturities, strengthens the balance sheet and reduces future refinancing risk. The ongoing transition of AlerisLife communities, while temporarily impacting labor costs, is a strategic move expected to normalize operations. Given the blend of financial challenges and clear operational and strategic progress, a 'hold' recommendation is appropriate. Investors should monitor the successful completion of the AlerisLife transitions, the impact of property dispositions on future revenue, and the company's ability to sustain operational improvements and further reduce leverage.

Keywords

Diversified Healthcare Trust, DHC, REIT, Healthcare Properties, Senior Housing, Medical Office, Life Science, Q3 2025 Earnings, Financial Results, SEC Filing, Real Estate Investment Trust, Occupancy Rates, Net Operating Income, Debt Refinancing, Property Dispositions, AlerisLife Transition, Normalized FFO, Adjusted EBITDAre, Corporate Real Estate